1 | A bill to be entitled |
2 | An act relating to patient safety; creating s. 381.0271, |
3 | F.S.; providing definitions; creating the Florida Patient |
4 | Safety Corporation; authorizing the corporation to create |
5 | not-for-profit corporate subsidiaries; specifying that the |
6 | corporation and certain subsidiaries are not government |
7 | agencies; requiring the corporation and certain |
8 | subsidiaries to be subject to public meetings and records |
9 | requirements; exempting the corporation and certain |
10 | subsidiaries from certain provisions relating to |
11 | procurement of personal property and services; providing a |
12 | purpose for the corporation; establishing the membership |
13 | of the board of directors of the corporation; requiring |
14 | certain advisory committees for the corporation; requiring |
15 | the Agency for Health Care Administration to provide |
16 | assistance in establishing the corporation; specifying the |
17 | powers and duties of the corporation; requiring annual |
18 | reports; requiring the corporation to seek private-sector |
19 | funding and apply for grants for certain purposes; |
20 | requiring the Office of Program Policy Analysis and |
21 | Government Accountability, the Agency for Health Care |
22 | Administration, and the Department of Health to develop |
23 | performance measures for the corporation; requiring a |
24 | performance audit; providing an effective date. |
25 |
|
26 | Be It Enacted by the Legislature of the State of Florida: |
27 |
|
28 | Section 1. Section 381.0271, Florida Statutes, is created |
29 | to read: |
30 | 381.0271 Florida Patient Safety Corporation.-- |
31 | (1) DEFINITIONS.--As used in this section, the term: |
32 | (a) "Adverse incident" has the meanings given to the term |
33 | in ss. 395.0197, 458.351, and 459.026. |
34 | (b) "Corporation" means the Florida Patient Safety |
35 | Corporation created in this section. |
36 | (c) "Patient safety data" has the meaning given to the |
37 | term in s. 766.1016. |
38 | (2) CREATION.-- |
39 | (a) There is created a not-for-profit corporation, to be |
40 | known as the Florida Patient Safety Corporation, which shall be |
41 | registered, incorporated, organized, and operated in compliance |
42 | with chapter 617. The corporation is authorized to create not- |
43 | for-profit corporate subsidiaries that are organized under the |
44 | provisions of chapter 617, upon the prior approval of the board |
45 | of directors, as necessary, to fulfill its mission. |
46 | (b) Neither the corporation nor any authorized and |
47 | approved subsidiary is an agency as defined in s. 20.03(11). |
48 | (c) The corporation and any authorized and approved |
49 | subsidiary are subject to the public meetings and records |
50 | requirements of s. 24, Art. I of the State Constitution, chapter |
51 | 119, and s. 286.011. |
52 | (d) The corporation and any authorized and approved |
53 | subsidiary are not subject to the provisions of chapter 287. |
54 | (e) The corporation is a patient safety organization as |
55 | defined in s. 766.1016. |
56 | (3) PURPOSE.-- |
57 | (a) The purpose of the Florida Patient Safety Corporation |
58 | is to serve as a learning organization dedicated to assisting |
59 | health care providers in the state to improve the quality and |
60 | safety of health care rendered and to reduce harm to patients. |
61 | The corporation shall promote the development of a culture of |
62 | patient safety in the health care system in the state. The |
63 | corporation shall not regulate health care providers in the |
64 | state. |
65 | (b) In the fulfillment of its purpose, the corporation |
66 | shall work with a consortium of patient safety centers within |
67 | the universities of the state and other patient safety centers |
68 | and programs. |
69 | (4) BOARD OF DIRECTORS; MEMBERSHIP.--The corporation shall |
70 | be governed by a board of directors. The board of directors |
71 | shall consist of: |
72 | (a) The chair of the Florida Council of Medical School |
73 | Deans. |
74 | (b) The person responsible for patient safety issues for |
75 | the authorized health insurer with the largest market share as |
76 | measured by premiums written in the state for the most recent |
77 | calendar year, appointed by such insurer. |
78 | (c) A representative of an authorized medical malpractice |
79 | insurer appointed by the insurers. |
80 | (d) The president of the Florida Health Care Coalition. |
81 | (e) A representative of a hospital in the state that is |
82 | implementing innovative patient safety initiatives, appointed by |
83 | the Florida Hospital Association. |
84 | (f) A physician with expertise in patient safety, |
85 | appointed by the Florida Medical Association. |
86 | (g) An osteopathic physician with expertise in patient |
87 | safety, appointed by the Florida Osteopathic Medical |
88 | Association. |
89 | (h) A podiatric physician with expertise in patient |
90 | safety, appointed by the Florida Podiatric Medical Association. |
91 | (i) A chiropractic physician with expertise in patient |
92 | safety, appointed by the Florida Chiropractic Association. |
93 | (j) A dentist with expertise in patient safety, appointed |
94 | by the Florida Dental Association. |
95 | (k) A nurse with expertise in patient safety, appointed by |
96 | the Florida Nurses Association. |
97 | (l) An institutional pharmacist, appointed by the Florida |
98 | Society of Health-System Pharmacists. |
99 | (m) A representative of Florida AARP, appointed by the |
100 | state director of Florida AARP. |
101 | (n) An independent consultant on health care information |
102 | systems, appointed jointly by the Central Florida Chapter and |
103 | the South Florida Chapter of the Healthcare Information and |
104 | Management Systems Society. |
105 | (5) ADVISORY COMMITTEES.--In addition to any committees |
106 | that the corporation may establish, the corporation shall |
107 | establish the following advisory committees: |
108 | (a) A scientific research advisory committee that |
109 | includes, at a minimum, a representative from each patient |
110 | safety center or other patient safety program in the |
111 | universities of the state. The duties of the scientific research |
112 | advisory committee shall include, but not be limited to, the |
113 | analysis of existing data and research to improve patient safety |
114 | and encourage evidence-based medicine. |
115 | (b) A technology advisory committee that includes, at a |
116 | minimum, a representative of a hospital that has implemented a |
117 | computerized physician order entry system and a health care |
118 | provider that has implemented an electronic medical records |
119 | system. The duties of the technology advisory committee shall |
120 | include, but not be limited to, implementation of new |
121 | technologies, including electronic medical records. |
122 | (c) A health care provider advisory committee that |
123 | includes, at a minimum, representatives of hospitals, ambulatory |
124 | surgical centers, physicians, nurses, and pharmacists licensed |
125 | in the state and a representative of the Veterans Integrated |
126 | Service Network 8. The duties of the health care provider |
127 | advisory committee shall include, but not be limited to, |
128 | promotion of a culture of patient safety that reduces errors. |
129 | (d) A health care consumer advisory committee that |
130 | includes, at a minimum, representatives of businesses that |
131 | provide health insurance coverage to their employees, consumer |
132 | advocacy groups, and representatives of patient safety |
133 | organizations. The duties of the health care consumer advisory |
134 | committee shall include, but not be limited to, identification |
135 | of incentives to encourage patient safety and the efficiency and |
136 | quality of care. |
137 | (e) A litigation alternatives advisory committee that |
138 | includes, at a minimum, representatives of medical malpractice |
139 | plaintiff's and defendant's attorneys and a representative of |
140 | each law school in the state. The duties of the litigation |
141 | alternatives advisory committee shall include, but not be |
142 | limited to, identification of alternative systems to compensate |
143 | for injuries. |
144 | (f) An education advisory committee that includes, at a |
145 | minimum, the associate dean for education, or the equivalent |
146 | position, as a representative from each school of medicine and |
147 | nursing to provide advice on the development, implementation, |
148 | and measurement of core competencies for patient safety to be |
149 | considered for incorporation in the educational programs of the |
150 | universities and colleges of the state. |
151 | (6) ORGANIZATION; MEETINGS.-- |
152 | (a) The Agency for Health Care Administration shall assist |
153 | the corporation in its organizational activities required under |
154 | chapter 617, including, but not limited to: |
155 | 1. Eliciting appointments for the initial board of |
156 | directors. |
157 | 2. Convening the first meeting of the board of directors |
158 | and assisting with other meetings of the board of directors, |
159 | upon request of the board of directors, during the first year of |
160 | operation of the corporation. |
161 | 3. Drafting articles of incorporation for the board of |
162 | directors and, upon request of the board of directors, |
163 | delivering articles of incorporation to the Department of State |
164 | for filing. |
165 | 4. Drafting proposed bylaws for the corporation. |
166 | 5. Paying fees related to incorporation. |
167 | 6. Providing office space and administrative support, at |
168 | the request of the board of directors, but not beyond July 1, |
169 | 2005. |
170 | (b) The board of directors must conduct its first meeting |
171 | no later than August 1, 2004, and shall meet thereafter as |
172 | frequently as necessary to carry out the duties of the |
173 | corporation. |
174 | (7) POWERS AND DUTIES.--In addition to the powers and |
175 | duties prescribed in chapter 617, and the articles and bylaws |
176 | adopted under that chapter, the corporation shall, either |
177 | directly or through contract: |
178 | (a) Secure staff necessary to properly administer the |
179 | corporation. |
180 | (b) Collect, analyze, and evaluate patient safety data, |
181 | quality and patient safety indicators, medical malpractice |
182 | closed claims, and adverse incidents reported to the Agency for |
183 | Health Care Administration and the Department of Health for the |
184 | purpose of recommending changes in practices and procedures that |
185 | may be implemented by health care practitioners and health care |
186 | facilities to improve health care quality and to prevent future |
187 | adverse incidents. Notwithstanding any other law, the Agency for |
188 | Health Care Administration and the Department of Health shall |
189 | make available to the corporation any adverse incident report |
190 | submitted under ss. 395.0197, 458.351, and 459.026. To the |
191 | extent that adverse incident reports submitted under s. 395.0197 |
192 | are confidential and exempt, the confidential and exempt status |
193 | of such reports must be maintained by the corporation. |
194 | (c) Establish a 3-year pilot project of a near-miss |
195 | patient safety reporting system. The purpose of this system is |
196 | to identify potential systemic problems that could lead to |
197 | adverse incidents, enable publication of system-wide alerts of |
198 | potential harm, and facilitate development of both facility- |
199 | specific and statewide options to avoid adverse incidents and |
200 | improve patient safety. The reporting system shall record near- |
201 | misses submitted by hospitals, birthing centers, ambulatory |
202 | surgical facilities, and other providers. For the purpose of the |
203 | reporting system: |
204 | 1. The term "near miss" means any potentially harmful |
205 | event that could have had an adverse result, but, through chance |
206 | or intervention, harm was prevented. |
207 | 2. The near-miss reporting system shall be voluntary, |
208 | anonymous, and independent of mandatory reporting systems used |
209 | for regulatory purposes. |
210 | 3. Data submitted to the corporation shall be de- |
211 | identified and shall not be discoverable or admissible in any |
212 | civil or administrative action. |
213 | 4. Reports of near-miss data shall be published on a |
214 | regular basis and special alerts shall be published as needed |
215 | regarding newly identified, significant risks. |
216 | 5. Aggregated near-miss data shall be made publicly |
217 | available. |
218 | 6. The corporation shall report the performance and |
219 | results of the reporting system pilot project in its annual |
220 | report. |
221 | (d) Foster the development of a statewide electronic |
222 | infrastructure, including implementation of statewide electronic |
223 | medical records systems, that may be implemented in phases over |
224 | a multiyear period and that is designed to improve patient care |
225 | and the delivery and quality of health care services by health |
226 | care facilities and health care practitioners. Support for |
227 | implementation of electronic medical records systems shall |
228 | include: |
229 | 1. A report to the Governor, the President of the Senate, |
230 | the Speaker of the House of Representatives, and the Agency for |
231 | Health Care Administration by January 1, 2005, identifying: |
232 | a. Public and private-sector initiatives relating to |
233 | electronic medical records and the communication systems used to |
234 | share clinical information among caregivers. |
235 | b. Regulatory barriers that interfere with the sharing of |
236 | clinical information among caregivers. |
237 | c. Investment incentives that might be used to promote the |
238 | use of recommended technologies by health care providers. |
239 | d. Educational strategies that may be implemented to |
240 | educate health care providers about the recommended technologies |
241 | for sharing clinical information. |
242 | 2. An implementation plan reported to the Governor, the |
243 | President of the Senate, the Speaker of the House of |
244 | Representatives, and the Agency for Health Care Administration |
245 | by September 1, 2005, that must include, but need not be limited |
246 | to, the capital investment required to begin implementing the |
247 | system, the costs of operating the system, the financial |
248 | incentives recommended to increase capital investment, data |
249 | concerning the providers initially committed to participating in |
250 | the system by region, the standards for systemic functionality |
251 | and features, any marketing plan to increase participation, and |
252 | implementation schedules for key components. |
253 | (e) Provide for access to an active library of evidence- |
254 | based medicine and patient safety practices, including the |
255 | emerging evidence supporting their retention or modification, |
256 | and make this information available to health care |
257 | practitioners, health care facilities, and the public. Support |
258 | for implementation of evidence-based medicine shall include: |
259 | 1. A report to the Governor, the President of the Senate, |
260 | the Speaker of the House of Representatives, and the Agency for |
261 | Health Care Administration by January 1, 2005, identifying: |
262 | a. The ability to join or support efforts for the use of |
263 | evidence-based medicine already underway, such as those of the |
264 | Leapfrog Group, the international group Bandolier, and the |
265 | Healthy Florida Foundation. |
266 | b. The means by which to promote research using Medicaid |
267 | and other data collected by the Agency for Health Care |
268 | Administration to identify and quantify the most cost-effective |
269 | treatment and interventions, including disease management and |
270 | prevention programs. |
271 | c. The means by which to encourage development of systems |
272 | to measure and reward providers who implement evidence-based |
273 | medical practices. |
274 | d. The review of other state and private initiatives and |
275 | published literature for promising approaches and the |
276 | dissemination of information about such initiatives and |
277 | literature to providers. |
278 | e. The encouragement of the state health care boards under |
279 | the Department of Health to regularly publish findings related |
280 | to the cost-effectiveness of disease-specific evidence-based |
281 | standards. |
282 | f. Public and private-sector initiatives related to |
283 | evidence-based medicine and communication systems for the |
284 | sharing of clinical information among caregivers. |
285 | g. Regulatory barriers that interfere with the sharing of |
286 | clinical information among caregivers. |
287 | 2. An implementation plan reported to the Governor, the |
288 | President of the Senate, the Speaker of the House of |
289 | Representatives, and the Agency for Health Care Administration |
290 | by September 1, 2005, that must include, but need not be limited |
291 | to, estimated costs and savings, capital investment |
292 | requirements, recommended investment incentives, initial |
293 | committed provider participation by region, standards of |
294 | functionality and features, a marketing plan, and implementation |
295 | schedules for key components. |
296 | (f) Develop and recommend core competencies in patient |
297 | safety that can be incorporated into the curriculums in schools |
298 | of medicine, nursing, and allied health in the state. |
299 | (g) Develop programs to educate the public about the role |
300 | of health care consumers in promoting patient safety. |
301 | (h) Provide recommendations for interagency coordination |
302 | of patient safety efforts in the state. |
303 | (8) ADDITIONAL POWERS.--In carrying out its powers and |
304 | duties, the corporation may also: |
305 | (a) Assess the patient safety culture at volunteering |
306 | hospitals and recommend methods to improve the working |
307 | environment related to patient safety at these hospitals. |
308 | (b) Inventory the information technology capabilities |
309 | related to patient safety of health care facilities and health |
310 | care practitioners and recommend a plan for expediting the |
311 | implementation of patient safety technologies statewide. |
312 | (c) Recommend continuing medical education regarding |
313 | patient safety to practicing health care practitioners. |
314 | (d) Study and facilitate the testing of litigation |
315 | alternative systems, including risk management, best practices, |
316 | and systems of compensating injured patients, as a means of |
317 | reducing and preventing medical errors and promoting patient |
318 | safety. |
319 | (9) ANNUAL REPORT.--By December 1, 2004, the corporation |
320 | shall prepare a report on the startup activities of the |
321 | corporation and any proposals for legislative action that are |
322 | needed for the corporation to fulfill its purposes under this |
323 | section. By December 1 of each year thereafter, the corporation |
324 | shall prepare a report for the preceding fiscal year. The |
325 | report, at a minimum, must include: |
326 | (a) A description of the activities of the corporation |
327 | under this section. |
328 | (b) Progress made in improving patient safety and reducing |
329 | medical errors. |
330 | (c) Policies and programs that have been implemented and |
331 | their outcomes. |
332 | (d) A compliance and financial audit of the accounts and |
333 | records of the corporation at the end of the preceding fiscal |
334 | year conducted by an independent certified public accountant. |
335 | (e) Recommendations for legislative action needed to |
336 | improve patient safety in the state. |
337 |
|
338 | The corporation shall submit the report to the Governor, the |
339 | President of the Senate, and the Speaker of the House of |
340 | Representatives. |
341 | (10) PRIVATE-SECTOR FUNDING AND GRANTS.--The corporation |
342 | is required to seek private-sector funding and apply for grants |
343 | to accomplish its goals and duties. |
344 | (11) PERFORMANCE EXPECTATIONS.--The Office of Program |
345 | Policy Analysis and Government Accountability, the Agency for |
346 | Health Care Administration, and the Department of Health shall |
347 | develop performance standards by which to measure the success of |
348 | the corporation in fulfilling the purposes established in this |
349 | section. Using the performance standards, the Office of Program |
350 | Policy Analysis and Government Accountability shall conduct a |
351 | performance audit of the corporation during 2006 and shall |
352 | submit a report to the Governor, the President of the Senate, |
353 | and the Speaker of the House of Representatives by January 1, |
354 | 2007. |
355 | Section 2. This act shall take effect July 1, 2004. |